208 related articles for article (PubMed ID: 26402135)
1. Asymptomatic Solitary Metastasis to the Testis From Prostate Carcinoma Detected by FDG PET/CT.
Hsieh TC; Lin CC; Kao CH; Wu YC; Sun SS
Clin Nucl Med; 2016 Jan; 41(1):86-7. PubMed ID: 26402135
[TBL] [Abstract][Full Text] [Related]
2. NUT Midline Carcinoma in Elderly Patients: Usefulness of 18F-FDG PET/CT for Treatment Assessment.
Kawase T; Naka G; Kubota K; Sakashita B; Takeda Y
Clin Nucl Med; 2015 Sep; 40(9):764-5. PubMed ID: 25899594
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT superscan in prostate cancer.
Bailly M; Besse H; Kerdraon R; Metrard G; Gauvain S
Clin Nucl Med; 2014 Oct; 39(10):912-4. PubMed ID: 24566401
[TBL] [Abstract][Full Text] [Related]
4. Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
Weber T; Ohlhauser D; Hillenbrand A; Henne-Bruns D; Reske SN; Luster M
Horm Metab Res; 2012 Nov; 44(12):904-8. PubMed ID: 22791600
[TBL] [Abstract][Full Text] [Related]
5. Re: 18F-FDG PET/CT Impact on Testicular Tumours Clinical Management.
Richie JP
J Urol; 2015 Oct; 194(4):991. PubMed ID: 26382779
[No Abstract] [Full Text] [Related]
6. [18F]Fluorodeoxyglucose positron emission tomography surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case report.
Ludwig V; Hopper OW; Martin WH; Kikkawa R; Delbeke D
Am Surg; 2003 Jul; 69(7):593-8. PubMed ID: 12889623
[TBL] [Abstract][Full Text] [Related]
7. Primary Prostatic Extragastrointestinal Stromal Tumor on 18F-FDG PET/CT.
Liu Y; Xu B
Clin Nucl Med; 2016 Mar; 41(3):224-6. PubMed ID: 26402134
[TBL] [Abstract][Full Text] [Related]
8. Widespread metastases in small cell carcinoma of the prostate on FDG PET/CT.
Yilmaz M; Celen Z; Sevinc A; Karakok M
Clin Nucl Med; 2009 Sep; 34(9):598-600. PubMed ID: 19692822
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT Demonstrated the Multiple Myeloma From Prostate.
Cheng A; Liping F; Wang X; Zhao L; Yang J
Clin Nucl Med; 2016 Apr; 41(4):328-30. PubMed ID: 26562573
[TBL] [Abstract][Full Text] [Related]
10. Splenic and multiple abdominal metastases of endometrial carcinoma detected with FDG-PET/CT.
Kara T; Kara PO; Gedik GK; Sari O
Rev Esp Med Nucl Imagen Mol; 2012; 31(1):31-3. PubMed ID: 21737185
[TBL] [Abstract][Full Text] [Related]
11. Melanoma metastasis to the testis demonstrated with FDG PET/CT.
Weng LJ; Schöder H
Clin Nucl Med; 2004 Dec; 29(12):811-2. PubMed ID: 15545888
[No Abstract] [Full Text] [Related]
12. MRI, enhanced CT, and FDG PET/CT in basal cell carcinoma of the prostate.
Dong A; Zuo C; Lu J; Wang Y
Clin Nucl Med; 2014 Aug; 39(8):721-4. PubMed ID: 24152659
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in urologic oncology: positron emission tomography molecular imaging.
Bouchelouche K; Oehr P
Curr Opin Oncol; 2008 May; 20(3):321-6. PubMed ID: 18391633
[TBL] [Abstract][Full Text] [Related]
14. Primary Testicular Serous Papillary Carcinoma With Extensive Calcification on CT and FDG PET/CT.
Sun D; Yu R; Geng D; Chen J; Zhang L
Clin Nucl Med; 2014 Oct; 39(10):894-7. PubMed ID: 24999690
[TBL] [Abstract][Full Text] [Related]
15. FDG in Urologic Malignancies.
Høilund-Carlsen PF; Poulsen MH; Petersen H; Hess S; Lund L
PET Clin; 2014 Oct; 9(4):457-68, vi. PubMed ID: 26050947
[TBL] [Abstract][Full Text] [Related]
16. A rare case of metastatic clear cell carcinoma of the Müllerian system originating from the peritoneum assessed by 18F-FDG PET/CT.
Treglia G; Barizzi J; Paone G; Ceriani L; Bongiovanni M; Giovanella L
Clin Nucl Med; 2015 Jan; 40(1):e58-60. PubMed ID: 24561679
[TBL] [Abstract][Full Text] [Related]
17. The combination of 13N-ammonia and 18F-FDG whole-body PET/CT on the same day for diagnosis of advanced prostate cancer.
Yi C; Yu D; Shi X; Zhang X; Luo G; He Q; Zhang X
Nucl Med Commun; 2016 Mar; 37(3):239-46. PubMed ID: 26588068
[TBL] [Abstract][Full Text] [Related]
18. The role of 18F-flourocholine PET/CT in biochemically relapsed prostate cancer: a case of osteolytic prostate metastasis.
Tabrizipour AI; Dunne M
Clin Nucl Med; 2015 May; 40(5):e285-6. PubMed ID: 25608148
[TBL] [Abstract][Full Text] [Related]
19. FDG PET/CT in evaluation of unusual cutaneous manifestations of breast cancer.
Dave SR; Samuel TA; Pucar D; Savage N; Williams HT
Clin Nucl Med; 2015 Jan; 40(1):e63-7. PubMed ID: 25140546
[TBL] [Abstract][Full Text] [Related]
20. Possible role of FDG-PET in the evaluation of urologic malignancies.
Bender H; Schomburg A; Albers P; Ruhlmann J; Biersack HJ
Anticancer Res; 1997; 17(3B):1655-60. PubMed ID: 9179213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
